Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein

Atherosclerosis

Volumn 161, Issue 2, 2002, Pages 395-402

  Van Jaarsveld, Henretha ^a   Pool, Gertruida F ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

Anti oxidants; Blood donation; High density lipoprotein; Iron; Oxidised low density lipoprotein

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A; FERRITIN; HIGH DENSITY LIPOPROTEIN; IRON; LOW DENSITY LIPOPROTEIN; NITRATE; NITRITE; TRANSFERRIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; BLOOD DONOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; IRON BLOOD LEVEL; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATION; PARAMETER; PRIORITY JOURNAL;

ANTIOXIDANTS; BLOOD DONORS; CARDIOVASCULAR DISEASES; CONFIDENCE INTERVALS; HUMANS; IRON; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0036119134     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00638-4     Document Type: Article

References (49)

1. Iron and LDL-oxidation in atherogenesis
2. The pathogenesis of atherosclerosis: An overview
3. Evolving lipoprotein risk factors: Lipoprotein (a) and oxidized low-density lipoprotein
4. Modified LDL - Trigger of atherosclerosis and inflammation in the arterial intima
5. Chemistry and pathophysiology of oxidation of LDL
6. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells
7. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men
8. Both intracellular and extracellular vitamin C inhibit atherosclerogenic modification of LDL by human vascular endothelial cells
9. The oxidative modification of low-density lipoproteins by macrophages
10. Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo
11. The effect of iron overload on rat plasma and liver oxidant status in vivo
12. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women
13. Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis
14. Iron, atherosclerosis, and ischemic heart disease
15. Association between body iron stores and the risk of acute myocardial infarction in men
16. Iron and heart disease: The epidemiologic data
17. Iron status and risk of cardiovascular disease
18. Ischemia/reperfusion injury is aggravated by an iron supplemented diet and is partly prevented by simultaneous antioxidant supplementation
19. Dietary iron elevates LDL-cholesterol and decreases plasma antioxidant levels: Influence of antioxidants
20. Dietary iron concentration alters LDL oxidatively: The effect of antioxidants
21. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland
22. Iron and the sex difference in heart disease risk
23. The sex differential in mortality from all causes and ischemic heart disease
24. Repeated blood donation effective in treating hyperlipidemia
25. Possible association of reduction in cardiovascular events with blood donation
26. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study
27. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: A randomized cross-over trial in male smokers
28. Blood donation, body iron stores, and risk of myocardial infarction
29. Give blood, live longer. It looks as though donors have a lower risk of heart attacks
30. Iron homeostasis and the assessment of iron status
31. Biochemical aspects of hematology - Iron metabolism
32. High-dose vitamin c: A risk for persons with high iron stores
33. Role of iron and oxygen derived free radicals in ischemia/reperfusion injury
34. The iron content of serum ferritin: Physiological importance and diagnostic value
35. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
36. Continuous monitoring of in vitro oxidation of human low density lipoprotein
37. Concurrent liquid-chromatography assay of retinol, α-tocopherol, β-carotene, α-carotene, lycopene and β-cryptoxanthin in plasma, with tocopherol acetate as internal standard
38. Quantitative determination of water-soluble scavengers in neoplastic and non-neoplastic human breast tissue
39. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein
40. Analysis of nitrite-nitrite, and [15N] nitrite in biological fluids
41. Atheroprotective mechanisms of HDL
42. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
43. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture
44. Antioxidants and coronary artery disease
45. High-dose vitamin C. A risk for persons with high iron stores
46. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects
47. Role of nitric oxide in cardiovascular disease: Focus on the endothelium
48. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: Evidence for biochemical assessment of the endothelial L-arginine-NO pathway
49. Iron regulates nitric oxide synthase activity by controlling nuclear transcription